1ml of tirzepatide Flex-Dose 3 mL Injectable 10 mg/mL Tirzepatide 40mg Injection Pen Kit

No pharmaceutical company has filed an IND to investigate it

A medical professional can review the persons medication list and adjust treatments as needed

Senior Safety Manager Medical Writer responsible for Clinical Disclosure Director, Drug Safety Operations Clinical Supply Manager Global Clinical Lead, Clinical Development, Migraine & Pain Pharmacokineticist, PK/PD Modelling & Simulation

I'll absolutely be transparent with the downsides of these compounds and try to give the best suggestions of how to use these compounds responsibly

They are truly equivalent from a safety standpoint

However, these agents are associated with increased thyroid cancer risk, and the packaging for these medications in the United States has a boxed warning stating that they are contraindicated in people with a personal or family history of medullary thyroid cancer and in patients with a diagnosis of multiple endocrine neoplasia syndrome type 2